Bcli final deadline tuesday: rosen, global investor counsel, encourages brainstorm cell therapeutics inc. investors with losses in excess of $500k to secure counsel before important january 2 deadline in securities class action filed by the firm - bcli

New york , dec. 30, 2023 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of brainstorm cell therapeutics inc. (nasdaq: bcli) between august 15, 2022 and september 27, 2023, both dates inclusive (the "class period"), of the important january 2, 2024 lead plaintiff deadline in the securities class action commenced by the firm. so what: if you purchased brainstorm cell securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
BCLI Ratings Summary
BCLI Quant Ranking